首页 | 本学科首页   官方微博 | 高级检索  
     检索      


NIPAAm-containing amphiphilic block copolymers with tailored LCST: Aggregation behavior,cytotoxicity and evaluation as carriers of indomethacin,tetracycline and doxorubicin
Authors:Lorenzo A Picos-Corrales  Melissa Garcia-Carrasco  Rocio A Chavez-Santoscoy  Sergio O Serna-Saldívar
Institution:1. Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Sinaloa, Culiacán, México;2. Centro de Graduados e Investigación en Química, Tecnológico Nacional de México/Instituto Tecnológico de Tijuana, Tijuana, México;3. Facultad de Ciencias Químicas e Ingeniería, Universidad Autónoma de Baja California-Campus Tijuana, Tijuana, México;4. Escuela de Biotecnología y Alimentos, Centro de Biotecnología FEMSA, Tecnológico de Monterrey-Campus Monterrey, Monterrey, México
Abstract:Nanocarriers based on amphiphilic block copolymers, with tailored temperature and pH responsiveness, were prepared. The hydrophilic blocks consist of temperature-sensitive N-isopropylacrylamide (NIPAAm)] or NIPAAm plus pH-sensitive units 5-methacryloyloxy pentatonic acid (5MPA) or 4-methacryloyloxy benzoic acid (4MBA)], while the hydrophobic block is composed of n-hexyl acrylate (HA) or styrene (ST). Particle sizes were within the suitable range for the desired application (30–182?nm). Drug loading was achieved via an organic solvent-free method and a THF-buffer method leading to drug loadings of indomethacin, tetracycline and doxorubicin of up to 11, 11 and 60?wt%, respectively. In vitro release kinetics were performed under simulated physiological conditions (pH 7.4 and 37?°C; pH 6.0 and 40?°C) and show differences depending on the copolymer composition. The average kinetic data were well fitted to the mathematical model of Peppas. NIPAAm-containing copolymers were slight or non-cytotoxic for rat primary hepatocytes at concentrations less than 200?µg mL?1. Some of the polymeric aggregates prepared may find application as pharmaceutical carriers.
Keywords:Polymeric drug delivery systems  pH-sensitive  cytotoxicity  nanocapsules  doxorubicin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号